REGN7544

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for REGN7544, covering 2024-08-12 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension [Phase 2]